Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) EBIT Margin (2019 - 2025)

Historic EBIT Margin for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to 6.07%.

  • Eton Pharmaceuticals' EBIT Margin fell 110000.0% to 6.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.89%, marking a year-over-year increase of 42400.0%. This contributed to the annual value of 6.66% for FY2024, which is 28900.0% down from last year.
  • Eton Pharmaceuticals' EBIT Margin amounted to 6.07% in Q3 2025, which was down 110000.0% from 7.79% recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' EBIT Margin registered a high of 45.08% during Q1 2021, and its lowest value of 754.45% during Q3 2021.
  • Moreover, its 5-year median value for EBIT Margin was 7.8% (2023), whereas its average is 63.36%.
  • The largest annual percentage gain for Eton Pharmaceuticals' EBIT Margin in the last 5 years was 226141900bps (2021), contrasted with its biggest fall of 2000000000bps (2021).
  • Over the past 5 years, Eton Pharmaceuticals' EBIT Margin (Quarter) stood at 21.57% in 2021, then tumbled by -42bps to 12.5% in 2022, then tumbled by -154bps to 6.69% in 2023, then surged by 181bps to 5.4% in 2024, then plummeted by -212bps to 6.07% in 2025.
  • Its last three reported values are 6.07% in Q3 2025, 7.79% for Q2 2025, and 26.32% during Q1 2025.